Static export generated 2026-07-31 07:45Z from the private Meridian research build — every value keeps its own as-of timestamp and provenance label; search, filters and admin actions are inactive in this copy. Private academic review only — not for redistribution.
MERIDIAN Regulatory & Corporate Impact Intelligence — personal research build

Regulatory instrument

Official record

Official Regulatory Fact — text as published by the source; topics are matching candidates, not legal conclusions.

FieldValue
Canonical identifier2026-13711
TitleRecission of the National Cancer Institute Clinical Cancer Education Program Regulation
AuthorityHealth and Human Services Department
JurisdictionUS
Typeproposed_rule
Legal stageproposal
Publication date2026-07-07
Discovered at2026-07-07T17:36:48Z
SR / CELEXn/a
Affected countries (parsed from title)none parsed
Matched topicspharma_health (clinical)
Original sourcehttps://www.federalregister.gov/documents/2026/07/07/2026-13711/recission-of-the-national-cancer-institute-clinical-cancer-education-program-regulation
Summary (as published)The Department of Health and Human Services (HHS), in consultation with the National Institutes of Health (NIH), is proposing to rescind the existing regulation concerning grants under the National Cancer Institute (NCI) Clinical Cancer Education Program because the regulation is obsolete and no longer necessary.
ⓘ